An Investigation of QBW251 in Healthy Volunteers

  • Research type

    Research Study

  • Full title

    A randomized placebo-controlled study to assess the safety, tolerability, pharmacokinetics, and preliminary pharmacodynamics of single and multiple ascending doses of QBW251 in healthy subjects and cystic fibrosis patients.

  • Contact name

    Salvatore Febbraro

  • Contact email

    salvatore.febbraro@simbec.co.uk

  • Sponsor organisation

    Novartis Institutes for BioMedical Research, Inc.

  • Eudract number

    2011-005085-37

  • ISRCTN Number

    1

  • Research summary

    The import did not bring in any data, please check the applicants form to see if they filled in the Research Summary. If so please import the form again. This problem may have been caused by the an application form being imported before the research summary functionality was available. Please phone the helpdesk if you have any questions.

  • REC name

    Wales REC 2

  • REC reference

    12/WA/0147

  • Date of REC Opinion

    18 May 2012

  • REC opinion

    Favourable Opinion